Preoperative Radiotherapy versus postoperative Radiotherapy after neoadjuvant Chemotherapy ("NeoRad") in High-risk Breast Cancer: a prospective, randomized, international multicenter Phase III Study

被引:0
|
作者
Matuschek, Christiane [1 ]
Jazmati, Danny [2 ]
Krug, David [3 ]
Corradini, Stefanie [4 ]
Fehm, Tanja [5 ]
Ruckhaeberle, Eugen [5 ]
Kuehn, Thorsten [6 ]
Stickeler, Elmar [7 ]
Nestle-Kraemling, Carolin [8 ]
Holtschmidt, Johannes [9 ]
Nekljudova, Valentina [9 ]
Loibl, Sibylle [9 ]
Budach, Wilfried [2 ]
机构
[1] Univ Bielefeld, Med Fak,Univ klin OWL, Univ klin Strahlentherapie & Radioonkol, Campus Klin Bielefeld, Teutoburger Str 50, D-33604 Bielefeld, Germany
[2] Heinrich Heine Univ Dusseldorf, Med Fak, Klin Strahlentherapie & Radiol Onkol, Dusseldorf, Germany
[3] Univ klin Hamburg Eppendorf, Klin Strahlentherapie, Klin Strahlentherapie & Radioonkol, MVZ, Hamburg, Germany
[4] LMU Munchen, Klin Radioonkol, Munich, Germany
[5] Univ klin Dusseldorf, Med Fak, Frauenklin, CIO ABCD, Dusseldorf, Germany
[6] Filderklin Stuttgart, Stuttgart, Germany
[7] Uniklin Aachen, Frauenklin, CIO ABCD, Aachen, Germany
[8] EVK Dusseldorf, Dusseldorf, Germany
[9] German Breast Grp, Neu Isenburg, Germany
来源
ONKOLOGIE | 2024年 / 30卷 / 09期
关键词
Brustkrebs; Bestrahlung; Neoadjuvanz; Krankheitsfreies uberleben; Nebenwirkungen; RADIATION-THERAPY;
D O I
10.1007/s00761-024-01568-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:840 / 844
页数:5
相关论文
共 50 条
  • [1] Präoperative Radiotherapie versus postoperative Radiotherapie nach neoadjuvanter Chemotherapie („NeoRad“) beim Hochrisikomammakarzinom: eine prospektive, randomisierte, internationale multizentrische Phase-III-StudiePreoperative radiotherapy versus postoperative radiotherapy after neoadjuvant chemotherapy (“NeoRad”) in high-risk breast cancer: a prospective randomized international multicenter phase III trial
    Christiane Matuschek
    Danny Jazmati
    David Krug
    Stefanie Corradini
    Tanja Fehm
    Eugen Ruckhäberle
    Thorsten Kühn
    Elmar Stickeler
    Carolin Nestle-Krämling
    Johannes Holtschmidt
    Valentina Nekljudova
    Sibylle Loibl
    Wilfried Budach
    Die Onkologie, 2024, 30 (9) : 840 - 844
  • [2] PREDICTIVE FACTORS OF SURVIVAL AFTER NEOADJUVANT RADIOTHERAPY AND CHEMOTHERAPY IN HIGH-RISK BREAST CANCER
    Matuschek, Christiane
    Budach, Wilfried
    Tamaskovics, Balint
    Fischer, Johannes
    Boelke, Edwin
    Corradini, Stefanie
    Kammers, Kai
    Kraemling, Carolin Nestle
    Fehm, Tanja
    Wollandt, Sylvia
    Speer, Vanessa
    Haussmann, Jan
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S38 - S39
  • [3] Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: A randomized, prospective, multicenter trial
    Lahousen, M
    Haas, J
    Pickel, H
    Hackl, A
    Kurz, C
    Ogris, H
    Stummvoll, W
    Winter, R
    GYNECOLOGIC ONCOLOGY, 1999, 73 (02) : 196 - 201
  • [4] Radiotherapy and chemotherapy in high-risk breast cancer
    Raffle, AE
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (05): : 331 - 331
  • [5] Postoperative radiotherapy in high-risk postmenopausal breast cancer
    Kunkler, IH
    LANCET, 1999, 354 (9181): : 865 - 865
  • [6] Neoadjuvant radiotherapy for locally advanced and high-risk breast cancer
    Chidley, Phoebe
    Foroudi, Farshad
    Tacey, Mark
    Khor, Richard
    Yeh, Janice
    Bevington, Elaine
    Hyett, Anthony
    Loh, Su Wen
    Chew, Grace
    McCracken, James
    Neoh, Derek
    Yeo, Belinda
    Baker, Caroline
    Jassal, Sunil
    Law, Michael
    Zantuck, Natalie
    Cokelek, Margaret
    Guerrieri, Mario
    Brown, Belinda
    Stoney, David
    Ng, Michael
    Chao, Michael
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2021, 65 (03) : 345 - 353
  • [7] Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer
    Haussmann, Jan
    Budach, Wilfried
    Nestle-Kraemling, Carolin
    Wollandt, Sylvia
    Tamaskovics, Balint
    Corradini, Stefanie
    Boelke, Edwin
    Krug, David
    Fehm, Tanja
    Ruckhaeberle, Eugen
    Audretsch, Werner
    Jazmati, Danny
    Matuschek, Christiane
    CANCERS, 2022, 14 (16)
  • [8] Postoperative radiotherapy in high-risk postmenopausal breast cancer - Reply
    Overgaard, M
    LANCET, 1999, 354 (9181): : 866 - 866
  • [9] Phase III randomized trial of CCRT versus neoadjuvant chemotherapy plus radiotherapy for NPC
    Lin, P. J.
    Liu, Y. C.
    Wang, W. Y.
    Lin, J. C.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S310 - S310
  • [10] Neoadjuvant Radiotherapy Versus Surgery Alone for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors A Prospective Multicenter Stratified Randomized Trial
    Deng, Xiangbing
    Liu, Ping
    Jiang, Dan
    Wei, Mingtian
    Wang, Xin
    Yang, Xuyang
    Zhang, Yuanchuan
    Wu, Bing
    Liu, Yanjun
    Qiu, Meng
    Zhuang, Hua
    Zhou, Zongguang
    Li, Yunfeng
    Xu, Feng
    Wang, Ziqiang
    ANNALS OF SURGERY, 2020, 272 (06) : 1060 - 1069